ClinicalTrials.gov
public full text
Public Domain
Influenza Immunity Against Pandemic Respiratory Virus
Sixty adults, ages 18-49, will be randomly assigned to receive either FluMist or Fluzone. Some of the subjects will have participated in previous studies for these 2 vaccines. The study will last 4 months with subject participation being 28 days. The purpose of this study is to measure immune response to the vaccinations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Proteomic Profiling for Influenza Vaccination - FluMist#967210
- Immunogenicity and Safety of Different Doses of Fluzone® Influenza#855837
- Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine#154738
- Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children#343682
- Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults#234507
Record · ID 1010808
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive